D. C. Kahraman Et Al. , "Sequential treatment of HCC cells with PI3K Akt mTOR pathway inhibitors prior to sorafenib attenuates cancer stem cell population," EACR 27 , vol.61, pp.77, 2016
Kahraman, D. C. Et Al. 2016. Sequential treatment of HCC cells with PI3K Akt mTOR pathway inhibitors prior to sorafenib attenuates cancer stem cell population. EACR 27 , 77.
Kahraman, D. C., Kahraman, T., & ATALAY, R., (2016). Sequential treatment of HCC cells with PI3K Akt mTOR pathway inhibitors prior to sorafenib attenuates cancer stem cell population . EACR 27 (pp.77).
Kahraman, DENİZ, Tamer Kahraman, And RENGÜL ATALAY. "Sequential treatment of HCC cells with PI3K Akt mTOR pathway inhibitors prior to sorafenib attenuates cancer stem cell population," EACR 27, 2016
Kahraman, DENİZ C. Et Al. "Sequential treatment of HCC cells with PI3K Akt mTOR pathway inhibitors prior to sorafenib attenuates cancer stem cell population." EACR 27 , pp.77, 2016
Kahraman, D. C. Kahraman, T. And ATALAY, R. (2016) . "Sequential treatment of HCC cells with PI3K Akt mTOR pathway inhibitors prior to sorafenib attenuates cancer stem cell population." EACR 27 , p.77.
@conferencepaper{conferencepaper, author={DENİZ CANSEN KAHRAMAN Et Al. }, title={Sequential treatment of HCC cells with PI3K Akt mTOR pathway inhibitors prior to sorafenib attenuates cancer stem cell population}, congress name={EACR 27}, city={}, country={}, year={2016}, pages={77} }